Recommended autoantibody panel for the evaluation of patients at risk for membranous nephropathy.
Semi-Quantitative Indirect Fluorescent Antibody
New York DOH Approval Status
Serum Separator Tube
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.2 mL)
Hemolyzed, hyperlipemic, icteric, heat-treated or contaminated
Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 month
|Phospholipase A2 Receptor, IgG||Less than 1:10|
|THSD7A Ab, IgG, Screen||Less than 1:10|
Refer to individual components.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
If Phospholipase A2 Receptor Antibody, IgG is positive, then a Phospholipase Receptor A2 Antibody, IgG titer will be added. Additional charges apply. If THSD7A Antibody, IgG is positive, then a THSD7A Antibody, IgG titer will be added.. Additional charges apply.
86255 x2; if reflexed, add 86256 x2
|Component Test Code*||Component Chart Name||LOINC|
|2011829||Phospholipase A2 Receptor, IgG||82991-1|
|3003478||THSD7A Ab, IgG, Screen||93339-0|